Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6180411 | Fertility and Sterility | 2012 | 4 Pages |
Abstract
The concept of using aromatase inhibitors in place of clomiphene citrate (CC) for ovulation induction was introduced >10 years ago; a brief history of its development is presented. Its worldwide usage for ovulation induction, including as an adjunct for intrauterine insemination and in vitro fertilization has occurred despite the absence of definitive data of superiority to CC. The results of two ongoing potentially definitive multicenter trials of efficacy and safety of letrozole compared with CC are eagerly awaited.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Robert F. M.D., Mohamed F.M. M.D., H.C.L.D.,